POLBF (Poolbeg Pharma) Price-to-Operating-Cash-Flow : (As of Apr. 27, 2025)

View and export this data going back to 2022. Start your Free Trial

What is Poolbeg Pharma Price-to-Operating-Cash-Flow?

As of today (2025-04-27), Poolbeg Pharma's share price is $0.118. Poolbeg Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.01. Hence, Poolbeg Pharma's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Poolbeg Pharma's Price-to-Operating-Cash-Flow or its related term are showing as below:

POLBF's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.58
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Poolbeg Pharma's Cash Flow from Operations per share for the six months ended in Jun. 2024 was $-0.01. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.01.

Poolbeg Pharma Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Poolbeg Pharma's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poolbeg Pharma Price-to-Operating-Cash-Flow Chart

Poolbeg Pharma Annual Data

Trend

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Poolbeg Pharma Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Poolbeg Pharma's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Poolbeg Pharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Poolbeg Pharma's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poolbeg Pharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Poolbeg Pharma's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Poolbeg Pharma Price-to-Operating-Cash-Flow Calculation

Poolbeg Pharma's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.118	/	-0.011
	=

Poolbeg Pharma's Share Price of today is $0.118.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Poolbeg Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.01.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Poolbeg Pharma Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Poolbeg Pharma's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Poolbeg Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poolbeg Pharma PLC (OTCPK:POLBF) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

POLB:UK 7JN:Germany

Address

42 New Road, Queen Mary BioEnterprises Innovation Centre, London, GBR, E1 2AX

Website

https://www.poolbegpharma.com

Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.